(Q34307105)

1 August 2017

1 reference

title

Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'. (English)

1 reference

1 August 2017

1

George L Drusano

1 reference

PubMed ID

15031728

1 August 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

Nature Reviews Microbiology

1 August 2017

1 reference

1 August 2017

2

1 reference

1 August 2017

289-300

1 reference

1 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/nrmicro862

1 August 2017

0 references

cites work

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Integration of pharmacokinetics and pharmacodynamics of imipenem in a human-adapted mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Pharmacodynamics of the new fluoroquinolone gatifloxacin in murine thigh and lung infection models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

21 January 2018

Does the dose matter?

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Pharmacodynamic effects of subinhibitory concentrations of beta-lactam antibiotics in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Hollow-fiber unit evaluation of a new human immunodeficiency virus type 1 protease inhibitor, BMS-232632, for determination of the linked pharmacodynamic variable

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Rational dose selection for a nonnucleoside reverse transcriptase inhibitor through use of population pharmacokinetic modeling and Monte Carlo simulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

The presence and sequence of endotracheal tube colonization in patients undergoing mechanical ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Optimal sampling schedule design for populations of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Pharmacodynamics of cefepime in patients with Gram-negative infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Incorporating prior parameter uncertainty in the design of sampling schedules for pharmacokinetic parameter estimation experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Implementation of OSPOP, an algorithm for the estimation of optimal sampling times in pharmacokinetics by the ED, EID and API criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Safety and pharmacokinetics of multiple 750-milligram doses of intravenous levofloxacin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Forecasting individual pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Factors influencing the emergence of resistance to indinavir: role of virologic, immunologic, and pharmacologic variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Continuous infusion of beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Levofloxacin population pharmacokinetics and creation of a demographic model for prediction of individual drug clearance in patients with serious community-acquired infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

"Continuous" vs. "discontinuous" therapy with penicillin; the effect of the interval between injections on therapeutic efficacy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Inhibition of cell wall synthesis and acylation of the penicillin binding proteins during prolonged exposure of growing Streptococcus pneumoniae to benzylpenicillin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Effect of protein binding on antibiotic activity in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Human serum alpha 1 acid glycoprotein reduces uptake, intracellular concentration, and antiviral activity of A-80987, an inhibitor of the human immunodeficiency virus type 1 protease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Bacterial colonization of endotracheal tubes in intubated neonates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Optimal sampling times for pharmacokinetic experiments

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Prevention of resistance: a goal for dose selection for antimicrobial agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

inferred from DOI database lookup

7 January 2021

based on heuristic

THE SLOW RECOVERY OF BACTERIA FROM THE TOXIC EFFECTS OF PENICILLIN.

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO862

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRMICRO862

1 reference

PubMed ID

15031728

Dimensions Publication ID

1 August 2017

0 references

1 reference

PubMed ID

15031728